<DOC>
	<DOCNO>NCT02242903</DOCNO>
	<brief_summary>The main purpose study evaluate safety well body handle single dose study drug , LY3079514 . This study last 12 week participant .</brief_summary>
	<brief_title>A Study LY3079514 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Overtly healthy participant determine medical history physical examination To qualify Japanese purpose study , Japanese participant must firstgeneration Japanese Have body mass index ( BMI ) 18.5 32.0 kilogram per square meter ( kg/m^2 ) minimum body weight 50 kilogram ( kg ) , inclusive screening Have clinical laboratory test result within normal reference range population investigator site , result acceptable deviation judge clinically significant investigator Have abnormality 12lead electrocardiogram ( ECG ) , opinion investigator , increase risk associate participate study Have abnormal blood pressure consider clinically significant , determined investigator Have history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data Have know ongoing psychiatric disorder Regularly use know drug abuse and/or show positive finding urinary drug screen Show evidence human immunodeficiency virus ( HIV ) infection and/or positive human HIV antibody Show evidence hepatitis C and/or positive hepatitis C antibody Show evidence hepatitis B and/or positive hepatitis B surface antigen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>